Hawranko, R.; Sohn, J.J.; Neiderer, K.; Bump, E.; Harris, T.; Fields, E.C.; Weiss, E.; Song, W.Y.
Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer. J. Clin. Med. 2022, 11, 2584.
https://doi.org/10.3390/jcm11092584
AMA Style
Hawranko R, Sohn JJ, Neiderer K, Bump E, Harris T, Fields EC, Weiss E, Song WY.
Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer. Journal of Clinical Medicine. 2022; 11(9):2584.
https://doi.org/10.3390/jcm11092584
Chicago/Turabian Style
Hawranko, Robert, James J. Sohn, Keith Neiderer, Ed Bump, Timothy Harris, Emma C. Fields, Elisabeth Weiss, and William Y. Song.
2022. "Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer" Journal of Clinical Medicine 11, no. 9: 2584.
https://doi.org/10.3390/jcm11092584
APA Style
Hawranko, R., Sohn, J. J., Neiderer, K., Bump, E., Harris, T., Fields, E. C., Weiss, E., & Song, W. Y.
(2022). Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer. Journal of Clinical Medicine, 11(9), 2584.
https://doi.org/10.3390/jcm11092584